1.
Introduction
Paraneoplastic neurological syndromes are a group of disorders which are postulated
to occur due to tumor-mediated immune dysfunction of the nervous system. Paraneoplastic
cerebellar degeneration (PCD) belongs to this category of rare disorders and can be
difficult to diagnose as there is no confirmatory test or diagnostic criteria available.
Presence of certain onco-neuronal antibodies either in cerebrospinal fluid (CSF) or
plasma is an important clinical clue and can further elucidate the origin of an underlying
malignancy. Regardless, the antibody testing also has limitations.
In addition, detection and treatment of the causative cancer is the cornerstone of
PCD management. However, a malignancy cannot always be diagnosed in all patients with
PCD who need aggressive immunotherapy and close cancer-surveillance.
We share an interesting case about a female patient who presented with symptoms of
cerebellar dysfunction and was diagnosed to have PCD based on positive CSF anti-Ta
antibodies. These antibodies are not usually seen in female population or patients
who present with PCD. Furthermore, a malignancy could not be detected despite a thorough
workup.
2.
Case description
An 80-year old lady with history of hypertension, hypothyroidism and osteoporosis
presented with slowly progressive dizziness, double vision, gait instability of 2-months
duration. At the time of presentation, her vitals including orthostatics were unremarkable.
Physical examination was unremarkable while a detailed neuro-ophthalmological exam
showed vertical diplopia on right lateral gaze, bilateral up-beating nystagmus and
ataxic gait concerning for a cerebellar/posterior fossa pathology. Initial results
blood workup including thyroid profile, Vitamin-D, Vitamin-B12, Lyme serology and
syphilis were unremarkable. Urinalysis, echocardiogram and EKG were also unremarkable.
CT head and MRI/MRA brain/neck/cervical spine showed no acute pathology. As her symptoms
remained unexplained, lumbar puncture was performed. CSF analysis was found to be
normal apart from mildly elevated protein level while additional autoimmune and paraneoplastic
results were awaited (Table 1). As patient remained stable, it was decided to transfer
her to a rehabilitation facility after which she could follow with neurology/neuro-ophthalmology
as outpatient.
10.1080/20009666.2019.1591900-T0001
Table 1.
Investigations performed for our patient.
Investigations
CSF analysis:
● Specific gravity: 1.005
● WBC: 2/mm3
● RBC: 1000/mm3
● Glucose: 57 mg/dl
● Protein: 51 mg/dl
● Gram stain and culture: Negative
● Fungal culture: Negative
● Cryptococcal antigen: Negative
● VDRL: Negative
● Viral panel: Negative
● Lyme serology: Negative
CSF immunology:
● Anti-Hu: Negative
● Anti-Ri: Negative
● Anti-Yo: Negative
● Anti-CV2: Negative
● Anti-amphiphysin: 1:4 (Normal 1:1)
● Anti-Ma1: 1:32 (Normal 1:1)
● Anti-Ma2/Anti-Ta: 1:32 (Normal 1:1)
Serum immunology:
● Acetylcholine receptor blocking/modulating Ab: Negative
● GAD65 Ab: Negative
● Amphiphysin Ab: Negative
● ANNA1 (Hu) Ab: Negative
● ANNA2 (Ri) Ab: Negative
● ANNA3 Ab: Negative
● PCA1 (Yo) Ab: Negative
● PCA2 Ab: Negative
● PCA-Tr Ab: Negative
● CRMP5/CV2 Ab: Negative
● AGNA/SOX1 Ab: Negative
● VGCC Ab: Negative
● VGKC Ab: Negative
● Striated muscle Ab: Negative
However, the patient’s current symptoms worsened over the next few days and she was
admitted with new-onset dysarthria, dysphagia and respiratory failure secondary to
aspiration. Repeat neuroimaging showed no acute abnormalities. She was immediately
intubated and started on intravenous corticosteroids. Meanwhile, her results from
the previous admission showed strongly positive anti-Ma, anti-Ta and weakly positive
anti-amphiphysin antibodies confirming the diagnosis of paraneoplastic cerebellar
dysfunction. This serology pattern was considered unusual as anti-Ta antibodies are
usually found in young males with an underlying testicular cancer. Nonetheless, intravenous
immunoglobulin therapy and workup for an underlying malignancy was commenced.
CT chest/abdomen/pelvis with contrast and tumor markers were unremarkable. A colonoscopy
done few months prior to admission and a mammogram done within the year of admission
didn’t show any abnormalities. A PET scan showed hypermetabolic uptake in gastro-esophageal
junction. However, esophagogastroscopy revealed an area of gastritis with no signs
of malignancy.
Even though a malignancy was unable to be identified in our patient, she continued
to improve slowly while receiving immunoglobulin therapy. Eventually, she was extubated
and then discharged to a rehabilitation facility. She continues to follow closely
with neurology as outpatient.
3.
Discussion
Paraneoplastic cerebellar degeneration (PCD) is one of the paraneoplastic neurological
syndromes (PNS) characterized by immune-mediated inflammation of the cerebellum. Although
invariably associated with cancers of different origin, the condition itself is not
caused by direct cancer invasion or the metastatic process. The mechanism behind PCD
is described to be a brain-specific immune phenomenon, either through antibodies or
T-cells, in response to tumor antigens [1]. The actual prevalence of PCD varies from
cancer to cancer but the overall estimated prevalence is approximately 1% in all patients
with cancer. The onset is usually acute with PCD preceding the actual cancer diagnosis
in almost 60% of the patients [2].
Making a timely diagnosis of PCD is a daunting task that requires a high index of
clinical suspicion for individuals with history of smoking, malignancy or autoimmunity
who present with suggestive features of truncal/appendicular ataxia, vertigo, nystagmus
and diplopia and in whom other common causes have been excluded. MRI with contrast
showing mild cerebellar enhancement and CSF pleocytosis can be seen in some patients
with PCD but are non-specific findings. Our patient presented with acute onset, rapidly
progressive suggestive of cerebellar dysfunction which remained unexplained despite
a detailed workup including toxicology, MRI brain/cervical spine, EEG and CSF analysis.
Detection of well characterized paraneoplastic antibodies in plasma or CSF can aid
in making a diagnosis (Table 2). These ‘onconeural’ antibodies are directed against
intra-cellular antigens mutually expressed by the tumor and neural tissue as opposed
to neural surface antibodies associated with non-paraneoplastic autoimmune neurological
syndromes.
10.1080/20009666.2019.1591900-T0002
Table 2.
Onconeural antibodies associated with paraneoplastic cerebellar degeneration [4].
Antibodies
Underlying malignancy
● Anti-Hu
Lung cancer, thymoma, neuroblastoma
● Anti-Yo
Ovarian, endometrial, breast cancer
● Anti-Ri
Lung and breast cancer
● Anti-Tr
Hodgkin’s lymphoma
● Anti-CRMP5
Lung cancer, thymoma
However, it should be kept in mind that only 60–70% of patients with PCD have detectable
onconeural antibodies while not all cancer patients with onconeural antibodies develop
PCD [3]. This is because these antibodies are tumor-specific only and while facilitating
a diagnosis, are used mainly for the detection of an underlying malignancy.
Our patient was an 80-year old female who presented with acute onset, rapidly progressive
symptoms suggestive of cerebellar dysfunction which remained unexplained despite a
detailed workup including toxicology, MRI brain/cervical spine, EEG and CSF analysis.
Presence of anti-Ta antibodies (also known as anti-Ma2) in CSF confirmed the diagnosis
of a paraneoplastic neurological condition; however, the unusual points of this case
are that patients with anti-Ta antibodies usually present with features suggestive
of paraneoplastic limbic encephalitis such as mood/behavior changes, cognitive dysfunction
and sleep disorders. PCD is an extremely rare disorder associated with these antibodies
[5]. Furthermore, anti-Ta antibodies are classically detected in young males with
an underlying testicular tumor [6].
On a detailed review of literature, we were able to find rare case reports of anti-Ta
associated PNS in older males and females. The malignancies detected in these patients
were lung cancer, breast cancer, parotid gland cancer and non-Hodgkin’s lymphoma [6,7].
Interestingly, our patient was also found to have anti-Ma1 antibodies. A study done
by Rosenfeld et al. showed that coexisting anti-Ma1 antibodies are more commonly detected
in PCD/PNS with tumors other than testicular cancer [6].
After the diagnosis of PCD is confirmed, management should be directed towards the
known malignancy as the treatment of malignancy itself resolves the neurological symptoms.
In patients with no known cancer, a thorough workup should be done with the help of
tumor markers, detailed imaging (MRI, PET scan) and exploratory procedures (colonoscopy,
exploratory laparotomy). However, cancer may not be detected even with extensive investigations
in some patients with PCD. In such cases, immunotherapy (corticosteroids, IVIG, plasmapheresis,
Rituximab) should be initiated in addition to serial cancer-surveillance [5]. The
clinical response in these patients is usually poor leading to significant debility
[8]. Interestingly, we encountered the exact opposite in our patient. An extensive
malignancy workup was unrevealing but patient demonstrated significant improvement
with eventual recovery after being treated with IVIG.
4.
Conclusion
This case highlights the clinical scenario when a rare disorder presents with unusual
manifestations. Paraneoplastic cerebellar degeneration is a clinical condition which
can be difficult to diagnose due to its rare occurrence. In addition, our patient
had clinical and serological features uncharacteristic of PCD such as an elderly female,
positive anti-Ta antibodies and an excellent response to immunotherapy in the absence
of an underlying malignancy.